Dublin based pharmaceuticals group Trinity Biotech has reported a marginal increase in pre-tax profits to $1.45 million for the first quarter of 2000. Sales in the quarter were 21 per cent higher on $8.3 million. The small increase in profits is attributed to higher expenses as a result of recent acquisitions as well as increased investment in sales and marketing.